278
Participants
Start Date
June 30, 2009
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
PEP005 (Ingenol Mebutate) gel, 0.015%
once daily for 3 consecutive days
Vehicle Gel
once daily for 3 consecutive days
South East Dermatology, Belmont Specialist Centre, Carina Heights
The Skin Centre, Benowa
Dermatology Associates of Rochester, PC, Rochester
The Education and Research Foundation, Lynchburg
Dermatology, Laser Vein Specialists of the Carolinas, Charlotte
North Florida Dermatology Associates, PA, Jacksonville
Laser Skin Surgery Center of Indiana, Carmel
The Indiana Clinical Trials Center, PC, Plainfield
Deaconess Clinic, Inc, Evansville
Altman Dermatology Associates, Arlington Heights
Burke Pharmaceutical Research, Hot Springs
Suzanne Bruce and Associates, PA, The Center for Skin Research, Houston
Progressive Clinical Research, San Antonio
DermResearch, Inc., Austin
Academic Dermatology Associates, Albuquerque
Karl G. Heine Dermatology, Henderson
Center for Dermatology, Fremont
Oregon Medical Research Center, PC, Portland
Premier Clinical Research, Spokane
Skin Specialists, PC, Omaha
Mount Sinai School of Medicine, New York
Lead Sponsor
Peplin
INDUSTRY